Xtant Medical Acquires Coflex and Cofix Product Lines for $17 Million
Xtant Medical Holdings, Inc. announced that it purchased the product lines of Coflex and Cofix from Surgalign Holdings, Inc. for $17 million. The deal closed on February 28, 2023. UBS Investment Bank served as the exclusive financial advisor and DLA Piper LLP served as legal counsel to Surgalign. Fox Rothschild LLP served as legal counsel to Xtant. Coflex is an interlaminar stabilization device used after an open decompression that can be performed in various settings, offering a non-fusion treatment option for lumbar spinal stenosis patients. Cofix is a supplemental fixation device, which is a minimally invasive system intended for use on all levels of the lumbar spine. Xtant Medical is a... Read More »
Globus Medical Merges With NuVasive in $3.1 Billion Deal
Globus Medical has announced its merger with San Diego-based NuVasive, Inc. in an all-stock deal valued at $3.1 billion. Following the close of the transaction, Globus Medical shareholders will own about 72% of the combined company and NuVasive shareholders will own the remaining 28%. NuVasive will allow Globus to support more patients and expand its commercial reach in the $50 billion global musculoskeletal market. The combined company will have an 11-member board composed of all eight directors from Globus Medical’s board and three directors from NuVasive’s board. The deal is expected to be completed by mid-2023. NuVasive is a medical device company based in San Diego. The... Read More »
Abbott Acquires Cardiovascular Systems for $890 Million
Abbott is expanding its cardiovascular device portfolio with its acquisition of Cardiovascular Systems. Under terms of the agreement, Cardiovascular Systems’ stockholders will receive $20 per common share at a total expected equity value of approximately $890 million. J.P. Morgan Securities LLC served as the financial advisor to Cardiovascular Systems. The transaction is expected to be neutral to Abbott’s 2023 ongoing earnings per share guidance. Cardiovascular Systems is a medical device company focused on the development and commercialization of solutions for treating complex peripheral vascular disease and coronary artery disease. Abbott manufactures and sells healthcare... Read More »
Ampersand-Backed Sterling Medical Devices Merges With RBC Medical Innovations
Sterling Medical Devices, a portfolio company of private equity firm Ampersand Capital Partners, announced on February 8 its recapitalization and simultaneous merger with RBC Medical Innovations. RBC brings additional design and development capacity, including expertise in energy-based electromechanical devices, as well as manufacturing capabilities to the combined organization. As part of the transaction, MedTech industry executive David Montecalvo has been appointed CEO of the combined company. Sterling Founder Dan Sterling will remain on the senior leadership team and a board director. RBC Founder Carl Mayer has joined the board of directors. RBC Medical Innovations is a medical device... Read More »
PE Firm Shore Capital Partners Sells Argentum Medical to BioDerm
Chicago-based private equity firm Shore Capital Partners announced the sale of Argentum Medical to BioDerm, a portfolio company of Denver-based private equity firm Mountaingate Capital. The transaction closed on January 31, 2023. Moelis & Company served as financial advisor to Argentum and Winston & Strawn LLP served as legal advisor to Shore and Argentum. Terms of the deal were not disclosed. Based in Geneva, Illinois, Argentum is a provider of infection prevention solutions for the management of wounds. Notably, it manufactures Silverlon, a silver-plated nylon dressing with unique antimicrobial properties. Argentum’s product lines include surgical, burn care, wound care, negative... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
